Non Invasive Neurostimulation Technology for the Treatment of Type I Complex Regional Pain Syndrome (CRPS I)

Launched by UNIVERSITY OF LAS PALMAS DE GRAN CANARIA · Sep 12, 2021

Keywords

ClinConnect Summary

This clinical trial is looking at a new way to help people with Type I Complex Regional Pain Syndrome (CRPS I), a condition that causes severe pain and other uncomfortable symptoms in the arms or legs. The study aims to see if adding a non-invasive treatment, called neuromodulation, to standard care can improve pain relief compared to standard care alone. Participants will receive either the neuromodulation treatment or a placebo (a treatment that has no active ingredients) while continuing their regular care.

To join the trial, participants need to be between 18 and 65 years old and have been diagnosed with CRPS I within the past six months. It's important that they have not experienced CRPS in more than one limb or had previous surgery to treat their symptoms. The trial is currently recruiting volunteers, and those who participate can expect to receive either the active treatment or a placebo, along with the usual care for their condition. Additionally, everyone involved will need to sign an agreement that they understand the study and are willing to participate.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Meet the Budapest criteria for the clinical diagnosis of CRPS type I.
• • Age between 18 and 65.
• • Period between 0 and 6 months after the onset of the clinical picture.
• • Have signed the informed consent of their own free will.
• Exclusion Criteria:
• • Have a diagnosis of CRPS type II.
• • Present type I CRPS in more than one limb.
• • Patients who have suffered a recurrence of CRPS type I.
• • Pregnancy or plans for it during the study.
• • Previous sympathectomy in the affected limb.